Viewing Study NCT00182767


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-03-21 @ 9:03 PM
Study NCT ID: NCT00182767
Status: COMPLETED
Last Update Posted: 2016-03-10
First Post: 2005-09-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: NCI-2009-00140
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators